Press release
Global Antibody Drug Conjugates Market Size, Regional Share, Top Key Players, Latest trends, Growth, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024
ntibody Drug Conjugates Market
Global antibody drug conjugates market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.
Market Outline: Global Antibody Drug Conjugates Market
Antibody drug conjugates (ADCs) are novel targeted therapy drugs for the treatment of cancer. ADCs are composed of monoclonal antibodies attached to biologically active drugs by chemical linkers. They have targeting property of monoclonal antibodies combine with cancer cell killing of cytotoxic drugs. ADCs are examples of immunoconjugates and bioconjugates.
Market Dynamics: Global Antibody Drug Conjugates Market
Increase in prevalence of cancer due to change in lifestyle such as consumption of alcohol and tobacco around the globe is a key factor drives the global antibody drug conjugates market. Moreover, rise in R&D for the innovation of newer drugs, pipeline products under the various stages of clinical trials, grow in collaborations between the research institutes for oncology research, and raise in funding from the public and private sectors for R&D are anticipated to fuel the global antibody drug conjugates market. However, stringent regulations for the product approval, less number of existed drugs in the market, and high cost and adverse effects of products are expected to dampen the global antibody drug conjugates market.
Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/#ulp-4H8Z4LpNMLEuOnnx
Market Scope: Global Antibody Drug Conjugates Market
Antibody drug conjugates market is segmented on the basis of product type, application, and distribution channel
Based on the product type, the market is segmented into the following:
• Kadcyla
• Adcertis
• Others
Based on the application, the market is segmented into the following:
• Leukemia
• Lymphoma
Based on the distribution channel, the market is segmented into the following:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/#ulp-c654SbFYO64MsOhu
Regional Analysis: Global Antibody Drug Conjugates Market
Geographically, global antibody drug conjugates market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America antibody drug conjugates market is poised to grow owing to rise in prevalence of various types of cancer, advancements in the newer cancer therapeutics by using nanotechnology, and recent FDA approval for the ADC molecules are anticipated to propel the market. Europe antibody drug conjugates market anticipated to offer lucrative opportunities due to increase in demand for antibody drug conjugate molecules, rise in R&D for the development of newer products, and presence of huge number of contract manufacturing companies. However, Asia Pacific antibody drug conjugates market is poised to grow at highest CAGR due to entry of market players into Asia Pacific countries, government support for the development of newer cancer therapeutics, and pipeline products.
Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/#ulp-14mlyhjMGhVjZqa3
Competition Assessment: Global Antibody Drug Conjugates Market
Some of the players in the global antibody drug conjugates market include:
• Roche Holding AG (Switzerland)
• Pfizer Inc. (U.S.)
• Bayer HealthCare (Germany)
• Progenics Pharmaceuticals (U.S.)
• Roche Holding AG (Switzerland)
• ImmunoGen, Inc. (U.S.)
• Celldex Therapeutics (U.S.)
• AbbVie Inc. (U.S.)
• Millennium Pharmaceuticals (U.S.)
• Agensys, Inc. (U.S.)
Notable Market Developments: Antibody Drug Conjugates Market
• In September 2017, Pfizer, Inc. received FDA approval for the Mylotarg (Gemtuzumab Ozogamicin), and antibody drug conjugate used in newly diagnosed and relapsed or refractory CD33-Positive acute myeloid leukemia.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/antibody-drug-conjugates-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Antibody Drug Conjugates Market Size, Regional Share, Top Key Players, Latest trends, Growth, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 here
News-ID: 1346226 • Views: …
More Releases from Precision Business Insights
Biochar Market Growth Is Attributed To The Increased Production Of Biochar Throu …
According to Precision Business Insights (PBI), the latest report biochar market was valued at USD 243.8 million in 2022, growing at a 12.6% CAGR during the forecast period 2023 to 2029. The rising demand for organic and eco-friendly products drives the biochar market. Utilizing biochar corresponds with organic farming methods, improving market prospects. Furthermore, biochar is a potential material for water treatment and remediation because of its capacity to absorb…
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Me …
According to Precision Business Insights (PBI), latest report vapor recovery units market was valued at USD 923.7 million in 2022 and is poised to grow at a CAGR of 4.2% during the forecast period 2023 to 2029. The adoption of stringent environmental regulations by governments and international bodies to reduce air pollution and greenhouse gas emissions in various countries drives the demand for the vapor recovery unit's market. Furthermore, the…
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
According to Precision Business Insights (PBI), latest report pyrite market is growing at 4.9% CAGR during the forecast period 2023 to 2029. The increased application of pyrite in the manufacturing of sulfuric acid drives the pyrite market. The increase of prices of gold has led to increased demand for imitation jewelry which is anticipated to propel the pyrite market growth. Furthermore, the demand for sulphuric acid in a variety of…
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Gen …
According to Precision Business Insights (PBI), the latest report industrial boilers market size was valued at USD 15,261.8 million in 2022 and is poised to grow at a 3.1% CAGR during the forecast period 2023 to 2029. The adoption of stringent environmental regulations to maintain emission standards and carbon reduction in several countries drives the industrial boilers market. Furthermore, the advancement in boiler technology, such as better combustion systems, greater…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
